Varda Launches Three Spacecraft for Orbital Drug Crystals
Varda Space Industries placed three returnable capsules into orbit in October 2026 to grow drug crystals in microgravity.
Updated on Nov. 8, 2026 in Space
Live Poll
Do you think space-made medicines will improve healthcare for ordinary people?
Varda Space Industries launched two spacecraft on October 1, 2026, and a third on October 20, 2026. The launch marked the first time a private company placed two returnable capsules into orbit simultaneously.
Why it matters
Microgravity can produce more uniform drug crystals than Earth-based methods, which may change how medicines dissolve and how long they stay stable. The mission also tests heat shield and navigation systems needed to bring samples back to Earth.
The spacecraft are similar in size to a standard washing machine and orbit approximately 480 km above the ground. One carries crystals of a candidate anticancer drug, while the other two test heat shield materials and navigation systems for return to Earth.
The players
Varda Space Industries
A private American company that builds returnable space capsules for manufacturing and testing in microgravity.
Space Forge
A United Kingdom-based company developing in-orbit manufacturing satellites and the recovery of their products to Earth.
The details
Unmanned mini-laboratories aboard each spacecraft conduct the experiments. When experiments finish, a capsule containing samples detaches, re-enters the atmosphere, deploys a parachute, and lands on Earth.
Timeline
February 2024: Varda recovered its first capsule containing ritonavir crystals.
June 2025: Space Forge, based in the United Kingdom, launched a manufacturing satellite.
December 2025: Space Forge generated high-temperature plasma in orbit.
October 1, 2026: Varda launched two spacecraft.
October 20, 2026: Varda launched a third spacecraft.
Roadmap
Varda's February 2024 recovery of a ritonavir-crystal capsule set the precedent for returnable drug manufacturing in orbit. The October 2026 launches extend that work with simultaneous capsules and a candidate anticancer drug, and the company plans seven missions in 2027 and ten in 2028.
Microgravity-grown drug crystals could eventually yield medicines with more predictable dissolution and longer shelf life. Commercialization timelines remain uncertain, and the mission's results have not yet been reported.
The takeaway
Private companies are moving from testing in orbit toward routine manufacturing and return of products to Earth. Readers should watch for published results from the anticancer drug crystal experiments.
What happens next
Varda plans seven additional space missions in 2027 and ten in 2028, and Space Forge targets demonstrating its full manufacturing-to-Earth-recovery process before 2030.
Further reading
Explore more on Space to see how private companies are building manufacturing capacity beyond Earth.
Source note: This article includes information reported by 조선일보.
Live Poll
Do you think space-made medicines will improve healthcare for ordinary people?
